Search by Drug Name or NDC
NDC 69097-0823-02 Citalopram 20 mg/1 Details
Citalopram 20 mg/1
Citalopram is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is CITALOPRAM HYDROBROMIDE.
MedlinePlus Drug Summary
Citalopram is used to treat depression. Citalopram is in a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs). It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.
Related Packages: 69097-0823-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Citalopram
Product Information
| NDC | 69097-0823 |
|---|---|
| Product ID | 69097-823_f6e72240-0d92-418a-b6d2-9658e8caf652 |
| Associated GPIs | 58160020100320 |
| GCN Sequence Number | 046203 |
| GCN Sequence Number Description | citalopram hydrobromide TABLET 20 MG ORAL |
| HIC3 | H2S |
| HIC3 Description | SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRIS) |
| GCN | 16342 |
| HICL Sequence Number | 010321 |
| HICL Sequence Number Description | CITALOPRAM HYDROBROMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Citalopram |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Citalopram |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | CITALOPRAM HYDROBROMIDE |
| Labeler Name | Cipla USA Inc. |
| Pharmaceutical Class | Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077534 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69097-0823-02 (69097082302)
| NDC Package Code | 69097-823-02 |
|---|---|
| Billing NDC | 69097082302 |
| Package | 30 TABLET in 1 BOTTLE (69097-823-02) |
| Marketing Start Date | 2016-07-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |